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Hermansky-Pudlak syndrome (HPS) is genetically heterogeneous, and mutations in seven genes have been reported
to cause HPS. Autozygosity mapping studies were undertaken in a large consanguineous family with HPS. Affected
individuals displayed features of incomplete oculocutaneous albinism and platelet dysfunction. Skin biopsy dem-
onstrated abnormal aggregates of melanosomes within basal epidermal keratinocytes. A homozygous germline
frameshift mutation in BLOC1S3 (p.Gln150ArgfsX75) was identiﬁed in all affected individuals. BLOC1S3 mu-
tations have not been previously described in patients with HPS, but BLOC1S3 encodes a subunit of the biogenesis
of lysosome-related organelles complex 1 (BLOC-1). Mutations in other BLOC-1 subunits have been associated
with an HPS phenotype in humans and/or mouse, and a nonsense mutation in the murine orthologue of BLOC1S3
causes the reduced pigmentation (rp) model of HPS. Interestingly, eye pigment formation is reported to be normal
in rp, but we found visual defects (nystagmus, iris transilluminancy, foveal hypoplasia, reduced visual acuity, and
evidence of optic pathway misrouting) in affected individuals. These ﬁndings deﬁne a novel form of human HPS
(HPS8) and extend genotype-phenotype correlations in HPS.
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Hermansky-Pudlak syndrome (HPS [MIM 203300]) is
an autosomal recessive disorder characterized by oculo-
cutaneous albinism and a bleeding diathesis secondary
to a platelet storage-pool deﬁciency caused by a lack of
dense bodies in platelets (Hermansky and Pudlak 1959).
HPS is genetically heterogeneous, and the severity of
skin, hair, and iris hypopigmentation and visual im-
pairment is variable. In addition, some patients develop
granulomatous colitis or pulmonary ﬁbrosis (Davies
and Tuddenham 1976; Schinella et al. 1980; Sandberg-
Gertzen et al. 1999). To date, HPS has been associated
with mutations in seven human genes—HPS1 (mouse
model pale ear) (MIM 604982), AP3B1/HPS2 (pearl)
(MIM 603401), HPS3 (cocoa) (MIM 606118), HPS4
(light ear) (MIM 606682), HPS5 (ruby-eye 2) (MIM
607521), HPS6 (ruby-eye) (MIM 607522), and HPS7/
Dysbindin (sandy) (MIM 607145) (see studies by
Dell’Angelica [2004] and Li et al. [2004] and references
therein). In addition, genes have been identiﬁed for an
additional nine mouse models of HPS that have not yet
been described in humans (mocha, pallid, gunmetal,
ashen, muted, buff, subtle gray, cappuccino, and reduced
pigmentation [rp]) (Dell’Angelica 2004; Li et al. 2004).
HPS appears to be a disorder of defective transport
of specialized organelles, such that the clinical symptoms
of hypopigmentation and impaired visual acuity (VA),
prolonged bleeding times, and ﬁbrotic lung disease are
caused by abnormal functions of melanosomes, platelet-
dense granules, and lysosomes, respectively. HPS2 is
caused by mutations in the b3A subunit of the hetero-
tetrameric AP-3 adapter complex that recruits cargo pro-
teins into clathrin vesicles for transport away from a
donor membrane within the Golgi apparatus, plasma
membrane, and/or endosomal compartments (Dell’An-
gelica et al. 1999). In addition, mutations in genes for
the murine HPS models gunmetal (encoding Rab ger-
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anylgeranyl transferase), ashen (encoding Rab27A), and
buff (encoding VPS33A) are implicated in intracellular
vesicular trafﬁcking (Dell’Angelica 2004). Other HPS
genes encode components of three protein complexes
of unknown function: biogenesis of lysosome-related
organelles complex (BLOC)–1, BLOC-2, and BLOC-3.
BLOC-2 comprises HPS6/ruby-eye, HPS5/ruby-eye-2,
and HPS3/cocoa, and BLOC-3 includes HPS1/pale ear
and HPS4/light ear. BLOC-1 was initially found to con-
sist of four proteins (pallidin, muted, cappuccino, and
HPS7/sandy) (Falcon-Perez et al. 2002). Recently, how-
ever, four additional BLOC-1 subunits were identiﬁed
(snapin, BLOS1, BLOS2, and BLOS3), and a nonsense
mutation in bloc1s3 was found in the rp mouse (Gwynn
et al. 2004; Starcevic and Dell’Angelica 2004). We used
an autozygosity mapping strategy to map a gene for
HPS (HPS8) to 19q13 and then identiﬁed a germline
BLOC1S3 mutation that causes a novel form of human
HPS.
The proband (IV:7; see ﬁg. 1) was referred at age 21
years for genetic counseling for “oculocutaneous albi-
nism.” He was born with silvery hair to Pakistani par-
ents who were ﬁrst cousins. His hair had slowly dark-
ened to a “gold” color, and he had hazel eyes and pale
skin that became red but did not tan in the sun (see ﬁg.
2). At that time, no history of bleeding or recurrent
infections was volunteered. On examination, there was
generalized hypopigmentation and reduced VA (right VA
[RVA] 6/60 and left VA [LVA] 6/60) with pendular nys-
tagmus and iris transillumination (see ﬁg. 2). Eye ex-
amination revealed optic disc cupping, pale fundi, and
moderate foveal hypoplasia. Visual evoked responses
demonstrated increased chiasmal decussation. Therewas
moderate hypermetropia with esotropia. A scalp skin
biopsy performed at age 24 years revealed aggregates of
abnormally small but fully melanized melanosomes (see
ﬁg. 2).
His second cousin (IV:2) was reviewed at age 12 years.
She had light-gold hair, hazel irises, pendular nystagmus,
iris transillumination, foveal hypoplasia, hypermetropic
astigmatism (corrected VA 6/60 in each eye), and gen-
eralized skin hypopigmentation and did not tan in the
sun. She developed an antecubital hematoma following
venesection, but platelet function studies were not per-
formed at that time. Subsequently, a history of menor-
rhagia was elicited.
IV:5, sister of the proband, was seen initially at age
15 years. She was reviewed at age 23 years, by which
time she had married a ﬁrst cousin and had two children,
one of whom (V:1) was affected. She has incomplete
oculocutaneous albinism with silvery hair, generalized
depigmentation, hazel irises, nystagmus, exotropia, and
high myopia, with VA of 6/36 in each eye.
IV:6 was seen at age 16 years. He was reported to
have cream-colored hair as a baby—but it had dark-
ened—and to have generalized depigmentation, pendu-
lar nystagmus, iris transillumination, foveal hypoplasia,
and high hypermetropia (corrected RVA 6/120 and LVA
6/60). After IV:13 received the diagnosis of HPS (see
below), IV:6 underwent hematological review, and a his-
tory of lifelong easy bruising and prolonged bleeding
from cuts was elicited. In addition, he described frequent
nose bleeds during childhood into early adulthood,
which required nasal cautery at age 23 years, and pro-
longed bleeding from a surgical wound after removal of
a lesion from his left thigh at age 11 years. He also
reported a history of bilateral frozen shoulder and Pey-
ronie disease.
V:1 has been followed by an ophthalmologist through-
out her life. At age 16 years, she has golden hair, pale
skin that does not tan, hazel-blue irises, pendular nys-
tagmus, iris transillumination, foveal hypoplasia, exo-
tropia, moderate myopic astigmatism, and VA 6/36 in
each eye.
IV:13 also received a diagnosis of “oculocutaneous
albinism,” because she had silver/gold hair and skin hy-
popigmentation with inability to tan, pale hazel irises,
pendular nystagmus, iris transillumination, foveal hy-
poplasia, mild hypermetropic astigmatism, and RVA 6/
60 and LVA 6/36. After the birth of her ﬁrst child at age
22 years, she bled excessively from an episiotomywound
and required a blood transfusion. A few months later,
major vaginal bleeding occurred that required hospital
management. Hematological review at age 26 years elic-
ited a history of lifelong easy bruising, menorrhagia since
menarche, excessive bleeding following incision and
drainage of a dental abscess, and excessive bleeding fol-
lowing gum surgery. Full blood count demonstrated mi-
crocytosis (mean cell volume 67.6 femtoliters [ﬂ] [nor-
mal range 78–99 ﬂ]; mean cell hemoglobin [MCH] 21.9
pg [normal 27.0–32.0 pg]; MCH concentration 32.4 g/
dl [normal 31.5–26.5 g/dl]) but no other abnormalities
(platelet count platelets/liter).111.98# 10
A skin sample from the scalp of IV:7 was processed
for transmission electron microscopy largely as de-
scribed elsewhere (Eady 1985) (see ﬁg. 2). The number
of epidermal melanocytes appeared normal, although
some of the cells were unusually small. Individual mel-
anocytes contained multiple fully melanized melano-
somes that were mainly small and round or ovoid, with
a vesicular or granular matrix. In ∼50% of basal ker-
atinocytes that were adjacent to melanocytes, melano-
somes were contained in membrane-bound aggregates.
The number and size of the aggregates were variable,
but aggregates contained up to 12 melanosomes. The
peripheral cytoplasm of the keratinocytes adjacent to the
melanocytes appeared edematous.
Platelet aggregation and secretion assays were under-
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Figure 2 Slit-lamp examination of the proband (IV:7) and trans-
mission electron micrograph. The legend is available in its entirety in
the online edition of The American Journal of Human Genetics.
Figure 1 A, Pedigree of consanguineous family from Pakistan with HPS. Blackened symbols represent patients affected with HPS. B,
Genotyping results of SNP GeneChip mapping 10K (Affymetrix) array on chromosome 19q in three individuals affected with HPS. Homozygous
genotypes are shaded in gray, heterozygous genotypes are unshaded, and black indicates no call. The position of BLOC1S3 is shown.
taken in two affected family members (IV:13 and IV:6)
and a volunteer who had not taken medication in the
past 10 d, by use of 50-ml blood samples and sodium
citrate (4%) as anticoagulant (9:1). Platelet aggrega-
tion and ATP secretion were monitored in platelet-rich
plasma (PRP) by use of a dual Chronolog lumi-aggre-
gometer (Atkinson et al. 2001). PRP was incubated in
the presence of luciferin-luciferase reagent before agonist
addition. ATP secretion in response to collagen, aden-
osine diphosphate (ADP), adrenaline, thrombin recep-
tor-activating peptide (TRAP), and arachidonic acid was
abolished in both affected individuals, whereas a robust
response to all ﬁve agonists was observed in the control
(ﬁg. 3A and data not shown). The delay in secretion
response to adrenaline in the control coincides with on-
set of secondary wave aggregation, whereas secretion
and secondary wave aggregation were absent in the
two patients (ﬁg. 3A). The absence of secretion is con-
sistent with the absence of dense granules in the two
patients—determined using electron microscopy (data
not shown)—a feature that is characteristic of HPS. Both
patients exhibited an impaired platelet-aggregation re-
sponse to low concentrations of collagen, TRAP, and
arachidonic acid and an absence of secondary wave ag-
gregation response to adrenaline. The impairment in
aggregation was overcome by high concentrations of
TRAP (ﬁg. 3A) and arachidonic acid, although there was
still a marked reduction in response to collagen (data
not shown). In contrast, the dose response curve to ADP
for aggregation for one of the patients was similar to
that observed in the control, whereas the other patient
exhibited irreversible aggregation response to ADP only
at concentrations in excess of 10 mM (not shown). The
relatively normal aggregation response to ADP is con-
sistent with the defect in aggregation to the other platelet
agonists being caused by the absence of dense-granule
secretion rather than by the impairment of ADP-medi-
ated receptor activation.
Platelet aggregation was further monitored after per-
fusion of whole blood on collagen as described elsewhere
(Auger et al. 2005). As shown in ﬁgure 3B, platelets
from a control donor exhibited formation of large plate-
let aggregates on collagen after perfusion for 4 min. In
contrast, a dramatic reduction in platelet aggregate size
was observed in the two BLOC1S3 donors, consistent
with the recognized role of secreted ADP in supporting
thrombus formation under arterial rates of ﬂow (Kuij-
pers et al. 2003). The defect in platelet aggregation under
ﬂow conditions is likely to account for the bleeding his-
tory of the two patients.
A genomewide linkage scan was performed using the
Affymetrix 10K SNP chip in three affected individuals
with HPS (IV:5, IV:7, and IV:13) (MRC GeneService).
Three regions of extended homozygosity shared by all
three individuals were identiﬁed and further analyzed
by typing microsatellite markers in all family members
from whom DNA was available. A common region of
homozygosity was apparent in all affected members for
a single marker, D19S902. This gave a minimal candi-
date region of 5.6 Mb between markers D19S559 and
D19S246 on chromosome 19q13. We noted that the hu-
man homologue of the gene disrupted in the rp mouse,
BLOC1S3, mapped to the target interval (see ﬁg. 1B),
and we proceeded to screen for a BLOC1S3 germline
mutation. The single coding exon was PCR ampliﬁed
(details available on request) and was sequenced from
forward and reverse strands on an ABI 3730 DNA an-
alyzer. This revealed that all affected individuals were
homozygous for a 1-bp frameshift deletion, c.448delC
(see ﬁg. 4). In the absence of nonsense-mediated decay,
the mutation was predicted to specify an abnormal 224-
aa protein (p.Gln150ArgfsX75; wild-type BLOC1S3
protein is 203 aa). Sequencing of all family members
demonstrated that the mutation segregated completely
with the disease haplotype, and the mutation was not
found in 210 ethnically matched control chromosomes.
To investigate possible mechanisms whereby the
c.448delC mutation might impair BLOC1S3 function,
wild-type and mutant BLOC1S3 coding sequences were
cloned into a pEGFP-C2 expression vector (BD Biosci-
ences Clontech) and were expressed in mouse malignant
melanoma cells (F1P43 cell-line, a generous gift fromDr.
Elena Sviderskaya, George’s Hospital Medical School,
University of London) (full details available on request).
Phase-contrast microscopy demonstrated that wild-type
BLOC1S3 (aa 1–203) was expressed in the cytoplasm,
but mutant, green ﬂuorescent protein (GFP)–labeled
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Figure 3 Platelet aggregation and secretion studies. A, Samples from the control and from a patient with BLOC1S3 mutation were
exposed to TRAP or adrenaline (Adr), and aggregation (i) and ATP secretion (ii) were monitored for 5 min. A similar set of results for TRAP
was observed in the other patient (not shown). B, A 5-ml sample of whole blood anticoagulated with P-Pack solution 40 mM (9:1) was perfused
over immoblized collagen for 4 min before perfusion with HEPES buffer for 5 min. Platelet aggregates were monitored using differential
interference contrast microscopy with a #20 lens. The results are representative of at least 10 different ﬁelds of view.
BLOC1S3 protein (aa 1–224) localized in the nucleus
(ﬁg. 4).
We describe a large family with HPS caused by a ho-
mozygous frameshift mutation in BLOC1S3. To our
knowledge, this has not been previously described in
human HPS, and so the BLOC1S3 mutation represents
the eighth known type of HPS in humans. HPS is a rare
disorder, but HPS1 has high prevalence in northwest
Puerto Rico (1/1,800) because of a founder mutation
(Witkop et al. 1990). Although we describe a single fam-
ily, we excluded linkage to BLOC1S3 in two other HPS-
affected families of Asian origin (data not shown), and
Gwynn et al. (2004) did not ﬁnd BLOC1S3 mutations
in a total of 15 probands with HPS, which suggests that
this is an infrequent cause of HPS.
Although the cardinal features of HPS—hypopigmen-
tation, impaired VA, and platelet dysfunction—werepre-
sent in this family, the bleeding tendency had not been
clinically apparent in some individuals. To date, no af-
fected individuals have shown clinical evidence of gran-
ulomatous colitis or pulmonary ﬁbrosis. Colitis has been
reported in HPS1, HPS3, and HPS4 but not HPS6, and
pulmonary ﬁbrosis in HPS1 and HPS4 but not HPS6
and HPS7 (Hermos et al. 2002; Anderson et al. 2003).
Thus, it would appear that HPS1 and HPS4 are asso-
ciated with a more severe phenotype than that seen in
our family with HPS8. Interestingly, the rp mouse dem-
onstrates coat hypopigmentation, increased bleeding
time, and a reduced number of platelet-dense bodies,
but both rp and gunmetalmice are unusual because their
www.ajhg.org Morgan et al.: BLOC1S3 Mutation Causes HPS8 165
Figure 4 Wild-type and mutant BLOC1S3 sequence traces and
localization patterns of wild-type and mutant proteins in malignant
melanoma cells. The legend is available in its entirety in the online
edition of The American Journal of Human Genetics.
eye pigment formation is normal (Swank et al. 1998;
Gwynn et al. 2004). These ﬁndings would suggest that
BLOC1S3 mutations are associated with a phenotype
milder than some other types of HPS. Elsewhere, it
was noted that, in mouse models of HPS, mutations in
genes for BLOC-1 components (e.g., pallid, cappuccino,
muted, and sandy) were associated with more-severe ef-
fects on coat color than mutations in genes for BLOC-
3 components (pale-ear/HPS1 and light ear/HPS4) (Li
et al. 2004). The rp mouse displays an intermediate coat
color. Thus, comparison of HPS subtype phenotypes in
humans and mice demonstrates little correlation be-
tween severity of effect on coat color and occurrence of
colitis and pulmonary ﬁbrosis in humans, suggesting that
different HPS protein complexes may affect distinct ves-
icle-trafﬁcking pathways and have tissue-speciﬁc effects.
In mouse models of HPS, the hypopigmentation is
mainly attributed to abnormal steps in the biogenesis of
melanosomes, and the morphological differences in skin
biopsies may be detected in different mouse models of
HPS (Nguyen et al. 2002). Studies of human HPS are
limited, although we found that, in our patient (IV:7),
there did not appear to be an increase in the number of
premelanosomes but melanosome aggregation was pre-
sent. Although aggregates containing up to 2–6 melan-
osomes are normal in the skin of whites and Asians
(Chinese), the aggregates in our patient comprised an
unusually high number of melanosomes, suggesting a
possible abnormality in transfer or packaging of these
organelles. We note that a patient with compound het-
erozygote mutations in the HPS1 gene was described as
having “giant melanosomes” in his melanocytes and ker-
atinocytes both in vivo and in culture (Horikawa et al.
2000).
The BLOC-1 complex is ubiquitously expressed and
contains BLOC1S3 and seven predicted coiled-coil–
forming proteins (Pallidin, Muted, Cappuccino, Dysbin-
din/HPS7, Snapin, BLOC1S1, and BLOC1S2) (Dell’An-
gelica 2004). Human BLOC1S3 encodes a 203-aa pro-
tein, and, in the mouse, wild-type rp encodes a 195-aa
protein. Mouse and human orthologues are 87% iden-
tical, and no orthologues have been described in yeast,
ﬂies, or worms (Gwynn et al. 2004). Although BLOC1S3
differs from other known BLOC-1 components in not
having a predicted coiled-coil domain, an unstructured
amino terminal domain is followed by a domain with a
high a-helical content, similar to that seen in Dysbindin/
HPS7/sandy. The precise function of the BLOC-1 com-
plex in vesicular transport is unknown, although Snapin
has been reported to interact with SNAP-23 and SNAP-
25, and Pallidin with Syntaxin 13; thus, it has been sug-
gested that BLOC-1 may regulate SNARE complex for-
mation at some step in the endocytic pathway (Starcevic
and Dell’Angelica 2004). We identiﬁed a frameshift mu-
tation in our family, and mutant rp/rp mice have a pre-
mature stop codon that is predicted to truncate the
bloc1s3/rp protein at 79 aa. Although we cannot exclude
nonsense-mediated decay in our family, and no evidence
of it was found in rp mice (Gwynn et al. 2004), our
ﬁndings suggest that the domains distal to codon 150
are critical for normal BLOC1S3 protein function.
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